In breast cancer, overexpression of CDK12 activates the WNT/β-catenin and PI3K–AKT pathways [41], while in gastric cancer CDK12 cooperates with PAK2 to sustain MAPK signaling [25]. This evidence concerns the gene CDK12 and breast cancer.